| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 605710 | 74823 | VIAFLO BICARBONATO SODICO 1,4%, SOLUCION PARA PERFUSION | VIAFLO BICARBONATO SODICO 1,4%, SOLUCION PARA PERFUSION, 20 bolsas de 500 ml | 1,4% (1/6 M) | 3 | 20 | 65 | 20 bolsas de 500 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74823/74823_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74823/74823_p.pdf | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 7980 | BAXTER S.L. | 2011-12-29 | 1 | 1 | 1 | 2011-12-29 | 2011-12-29 | 0 | 2013-11-22 | View Edit Delete | ||||||||||||
| 607812 | 45544 | BICARBONATO SODICO 1/6 M MEIN SOLUCION PARA PERFUSION | BICARBONATO SODICO 1/6 M MEIN SOLUCION PARA PERFUSION, 12 frascos de 250 ml | 1,4% (1/6 M) | 6 | 12 | 48 | 12 frascos de 250 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/45544/45544_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/45544/45544_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 1968-03-01 | 1 | 1 | 1 | 1968-03-01 | 2001-01-17 | 0 | 2011-02-09 | View Edit Delete | ||||||||||||
| 607838 | 45544 | BICARBONATO SODICO 1/6 M MEIN SOLUCION PARA PERFUSION | BICARBONATO SODICO 1/6 M MEIN SOLUCION PARA PERFUSION, 12 frascos de 500 ml | 1,4% (1/6 M) | 6 | 12 | 48 | 12 frascos de 500 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/45544/45544_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/45544/45544_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 1968-03-01 | 1 | 1 | 1 | 1968-03-01 | 2001-01-17 | 0 | 2011-02-09 | View Edit Delete | ||||||||||||
| 688703 | 75643 | GLYCILAX NIÑOS SUPOSITORIOS | GLYCILAX NIÑOS SUPOSITORIOS , 15 supositorios | 1,44 g | 5 | 15 | 33 | 15 supositorios | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75643/75643_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75643/75643_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2012-03-20 | 1 | 1 | 1 | 2012-03-20 | 2012-03-20 | 1 | 2012-11-08 | View Edit Delete | ||||||||||||
| 766223 | 1241836002 | GALLIAPHARM 1,48 GBQ GENERADOR DE RADIONUCLIDOS | GALLIAPHARM 1,48 GBQ GENERADOR DE RADIONUCLIDOS, 1 generador de radionúclidos | 1,48 GBq | 92 | 1 | 50 | 1 generador de radionúclidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1241836002/1241836002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241836002/1241836002_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 12588 | NUCLIBER, S.A. | 2024-11-14 | 1 | 1 | 1 | 2024-11-15 | 2024-11-14 | 0 | 2026-05-13 | View Edit Delete | ||||||||||||
| 607322 | 58329 | ALMAX FORTE 1,5 g SUSPENSION ORAL | ALMAX FORTE 1,5 g SUSPENSION ORAL,506 sobres | 1,5 g | 35 | 506 | 64 | 506 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/58329/58329_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/58329/58329_p.pdf | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 88187 | ALMIRALL S.A. | 1989-12-01 | 1 | 1 | 1 | 1989-12-01 | 2019-11-27 | 1 | 2020-01-13 | View Edit Delete | ||||||||||||
| 688743 | 40359 | SUPOSITORIOS DE GLICERINA VILARDELL NIÑOS | SUPOSITORIOS DE GLICERINA VILARDELL NIÑOS, 12 supositorios | 1,5 g | 5 | 12 | 33 | 12 supositorios | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/40359/40359_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/40359/40359_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3045 | LABORATORIOS VILARDELL S.A. | 1965-01-01 | 1 | 1 | 1 | 1965-01-01 | 2012-03-15 | 1 | 2012-10-09 | View Edit Delete | ||||||||||||
| 711185 | 58329 | ALMAX FORTE 1,5 g SUSPENSION ORAL | ALMAX FORTE 1,5 g SUSPENSION ORAL,12 sobres | 1,5 g | 35 | 12 | 64 | 12 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/58329/58329_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/58329/58329_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 88187 | ALMIRALL S.A. | 1989-12-01 | 1 | 1 | 1 | 1989-12-01 | 2016-06-10 | 1 | 2016-10-01 | View Edit Delete | ||||||||||||
| 711187 | 58329 | ALMAX FORTE 1,5 g SUSPENSION ORAL | ALMAX FORTE 1,5 g SUSPENSION ORAL,24 sobres | 1,5 g | 35 | 24 | 64 | 24 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/58329/58329_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/58329/58329_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 88187 | ALMIRALL S.A. | 1989-12-01 | 1 | 1 | 1 | 1989-12-01 | 2016-06-10 | 1 | 2016-10-01 | View Edit Delete | ||||||||||||
| 855056 | 40359 | SUPOSITORIOS DE GLICERINA VILARDELL NIÑOS | SUPOSITORIOS DE GLICERINA VILARDELL NIÑOS, 18 supositorios | 1,5 g | 23 | 18 | 33 | 18 supositorios | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/40359/40359_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/40359/40359_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3045 | LABORATORIOS VILARDELL S.A. | 1965-01-01 | 1 | 1 | 1 | 1965-01-01 | 1965-01-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 603564 | 73132 | BROMAZEPAM NORMON 1,5 mg CAPSULAS DURAS EFG | BROMAZEPAM NORMON 1,5 mg CAPSULAS DURAS EFG, 500 cápsulas | 1,5 mg | 5 | 500 | 43 | 500 cápsulas | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73132/73132_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73132/73132_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2010-12-01 | 1 | 1 | 1 | 2010-12-01 | 2010-12-01 | 1 | 2011-04-04 | Lista IV | View Edit Delete | |||||||||||
| 653694 | 67515 | POSTINOR 1,5 mg COMPRIMIDO | POSTINOR 1,5 mg COMPRIMIDO , 1 comprimido | 1,5 mg | 5 | 1 | 10 | 1 comprimido | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67515/67515_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67515/67515_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8334 | GEDEON RICHTER IBERICA S.A. | 2006-01-27 | 1 | 1 | 1 | 2006-01-27 | 2006-01-27 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 654322 | 67770 | NORLEVO 1,5 MG COMPRIMIDO | NORLEVO 1,5 MG COMPRIMIDO , 1 comprimido | 1,5 mg | 5 | 1 | 10 | 1 comprimido | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67770/67770_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67770/67770_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30116 | PERRIGO ESPANA S.A. | 2006-04-26 | 1 | 1 | 1 | 2006-04-26 | 2006-04-26 | 1 | 2011-09-30 | View Edit Delete | ||||||||||||
| 655896 | 02206006 | ARIXTRA 1,5 MG/0,3 ML SOLUCION INYECTABLE, JERINGA PRECARGADA | ARIXTRA 1,5 MG/0,3 ML SOLUCION INYECTABLE, JERINGA PRECARGADA, 7 jeringas precargadas de 0,3 ml | 1,5 mg | 33 | 7 | 61 | 7 jeringas precargadas de 0,3 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/02206006/02206006_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/02206006/02206006_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38090 | VIATRIS PHARMACEUTICALS S.L. | 2006-07-17 | 1 | 1 | 1 | 2006-07-17 | 2006-07-17 | 1 | 2011-09-19 | View Edit Delete | ||||||||||||
| 660219 | 69457 | INDAPAMIDA RETARD MABO 1,5 mg COMPRIMIDOS DE LIBERACION PROLONGADA EFG | INDAPAMIDA RETARD MABO 1,5 mg COMPRIMIDOS DE LIBERACION PROLONGADA EFG, 30 comprimidos | 1,5 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69457/69457_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69457/69457_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 68134 | MABO FARMA S.A. | 2007-12-04 | 1 | 1 | 1 | 2007-12-04 | 2007-12-04 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 659318 | 98066003 | EXELON 1,5 mg CAPSULAS DURAS | EXELON 1,5 mg CAPSULAS DURAS, 112 cápsulas | 1,5 mg | 5 | 112 | 43 | 112 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/98066003/98066003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/98066003/98066003_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 1998-12-01 | 1 | 1 | 1 | 1998-12-01 | 1998-12-01 | 0 | 2011-02-24 | View Edit Delete | ||||||||||||
| 659326 | 98066002 | EXELON 1,5 mg CAPSULAS DURAS | EXELON 1,5 mg CAPSULAS DURAS, 56 cápsulas | 1,5 mg | 5 | 56 | 43 | 56 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/98066002/98066002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/98066002/98066002_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 1998-12-01 | 1 | 1 | 1 | 1998-12-01 | 1998-12-01 | 0 | 2011-02-24 | View Edit Delete | ||||||||||||
| 659334 | 98066001 | EXELON 1,5 mg CAPSULAS DURAS | EXELON 1,5 mg CAPSULAS DURAS, 28 cápsulas | 1,5 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/98066001/98066001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/98066001/98066001_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 1998-12-01 | 1 | 1 | 1 | 1998-12-01 | 1998-12-01 | 0 | 2011-02-24 | View Edit Delete | ||||||||||||
| 660104 | 69391 | INDAPAMIDA RETARD KERN PHARMA 1,5 mg COMPRIMIDOS DE LIBERACION PROLONGADA EFG | INDAPAMIDA RETARD KERN PHARMA 1,5 mg COMPRIMIDOS DE LIBERACION PROLONGADA EFG , 30 comprimidos | 1,5 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69391/69391_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69391/69391_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2007-11-12 | 1 | 1 | 1 | 2007-11-12 | 2007-11-12 | 1 | 2011-10-17 | View Edit Delete | ||||||||||||
| 661472 | 70059 | INDAPAMIDA RETARD CINFA 1,5 mg COMPRIMIDOS DE LIBERACION PROLONGADA EFG | INDAPAMIDA RETARD CINFA 1,5 mg COMPRIMIDOS DE LIBERACION PROLONGADA EFG , 30 comprimidos | 1,5 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70059/70059_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70059/70059_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2008-09-19 | 1 | 1 | 1 | 2008-09-19 | 2008-09-19 | 1 | 2011-10-19 | View Edit Delete |
Page 78 of 1035, showing 20 records out of 20697 total, starting on record 1541, ending on 1560